view article
Figure 3
(a) Decay of apoferritin XEOL spectra as a function of absorbed dose and (b) the concomitant decay of diffracting power and luminescence (both overall and at the peak XEOL wavelength) of the same apoferritin crystal as a function of absorbed dose. XEOL decay is tracked both as a function of the normalized intensity at 494 nm (maximum of initial spectra; black squares) and the overall luminescence yield (as defined in §2.2.2[link]; red circles). The decay in normalized diffracting power is also shown (as defined in §2.2.1[link]; blue triangles). All data were collected on X10SA at SLS.

Journal logoBIOLOGICAL
CRYSTALLOGRAPHY
ISSN: 1399-0047
Volume 68| Part 5| April 2012| Pages 505-510
doi:10.1107/S0907444912002946
Follow Acta Cryst. D
Sign up for e-alerts
E-alerts
Follow Acta Cryst. on Twitter
Twitter
Follow us on facebook
Facebook
Sign up for RSS feeds
RSS